The US Food and Drug Administration (FDA) has launched a new programme aimed at accelerating the development of potential treatments for Covid-19 infection.
Under the Coronavirus Treatment Acceleration Program (CTAP), FDA is working to quickly bring therapies to patients.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Furthermore, the agency is supporting research to validate the safety and effectiveness of these Covid-19 treatments.
